| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |